메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

회사소개

History

2020
  • 10
    · Selection of the development of vaccine commercialization technology project by Ministry of Health Welfare
  • 09
    · Completion of Osong Bio Plant (GMP facility) Construction
  • 07
    · KIAT 2020 BIG3 SMEs selection of innovative growth support tasks
  • 06
    · Development of Prime-Boost TB vaccines by Chungnam National University, Yonsei University, Quratis and Institut Pasteur were selected as project supported by RIGHT Fund
  • 06
    · Selection of industry-academic Collabo R&D project by Ministry of SMEs and Startups
  • 06
    · Selection of startup scale-up package by Ministry of SMEs and Startups
  • 06
    · Capital increase KRW 10.84 Billion
  • 01
    · Phase 1 TB vaccine in adolescents: interim results completed
  • 01
    · Selection of research driven hospital promotion R&D project by Ministry of Health Welfare
2019
  • 12
    · 2019 Grand Prize for Technology Innovation from Minister,
    Ministry of SMEs and Startups
  • 12
    · 2019 Grand Prize for Bio from Ministry of Trade,
    Industry and Energy
  • 10
    · Selection of a porcine circovirus vaccine development
    project proposed by the Seoul Business Agency
  • 08
    · Phase 2a TB vaccine in adults: interim results completed
  • 06
    · Selection of antibiotic-resistant antimicrobial agent project
    supported by the Ministry of SMEs and Startups
  • 05
    · Start of Osong plant construction
  • 01
    · Selection of formulation development project in Cheombok Complex
2018
  • 12
    · Phase 1 IND approval for TB vaccine for adolescents
  • 09
    · Phase 1 IND application for TB vaccine for adolescents
  • 08
    · Capital increase KRW 2 Billion
  • 04
    · Selection of KIT safety pharmacology test project
  • 03
    · Plant site purchase agreement in Osong
2017
  • 12
    · Phase 2a IND approval for TB vaccine for adults
  • 10
    · Capital increase KRW 1.8 Billion
  • 08
    · Phase 2a IND application for TB vaccine for adults
  • 06
    · Finalization of Licensing Agreement with IDRI
  • 05
    · Capital increase KRW 1.1 Billion
  • 01
    · Accredited as a Research Center by the Ministry of Health & Welfare
2016
  • 12
    · Establishment of a R&D Center
  • 07
    · Establishment of Quratis Inc